12
Participants
Start Date
December 31, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
paclitaxel
Paclitaxel 135 mg/m\^2 intravenously on day 6 over 180 minutes. Cycles are repeated every 21 days.
CBT-1(Registered Trademark)
CBT-1 500 mg/m\^2 oral dose daily for 7 days in divided doses 3 times a day. Cycle days 1-7, repeated every 21 days. no antacids, H2 blocker, or gastric acid inhibiting agents will be administered within 4 hours before or after each daily dose.
Tc 99m sestamibi
20 mCI baseline scan day 0; 20 mCI scan on 6th day of CBT-1 administered.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH